Tioga Pharmaceuticals, Inc.

Investors

Tioga's Institutional Investors:

Forward Ventures, founded in 1993, is a leading life-science venture capital firm located in San Diego. Forward Ventures has a team of investment professionals with extensive experience in entrepreneurship, venture capital and operations.
Our firm has invested in over 50 companies since it was founded in 1993 and currently has more than $500 million in capital under management. Visit Forward Ventures's site.

New Leaf Venture Partners is a leader in healthcare technology venture investing. Our investment professionals bring a unique blend of technological, clinical, and operational experience to our investments. We work closely with our entrepreneurs to help build successful portfolio companies.
We focus primarily on later stage biopharmaceutical products, early stage medical devices, and laboratory infrastructure technologies. Visit New Leaf Venture Partners's site.

BB BIOTECH VENTURES is a healthcare-dedicated venture capital fund, focused on companies that develop and market drugs and medical devices. Visit BB BIOTECH VENTURES's site.

Genesys Capital is focused on building companies in the high-growth sectors of healthcare and biotechnology. Through its expertise and network, Genesys accelerates the development of commercially viable emerging companies that represent promising life science investment opportunities. Visit Genesys Capital’s site.

Thomas, McNerney & Partners is a venture capital firm that invests in life science and medical technology companies.  Employing a multi-stage investment approach, Thomas, McNerney & Partners has $600 million in assets under management and provides seed and early stage funding to help entrepreneurs launch companies, as well as growth capital to emerging companies for furthering clinical development or for expansion of product commercialization.  Visit Thomas, McNerney & Partners’ site.